Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-83,000
Closed -$1.83M – 1270
2021
Q1
$1.83M Sell
83,000
-55,500
-40% -$1.14M 0.01% 813
2020
Q4
$2.59M Buy
138,500
+64,500
+87% +$1.16M 0.02% 740
2020
Q3
$1.15M Buy
+74,000
New +$1.14M 0.01% 991
2020
Q1
– Sell
-89,026
Closed -$2.14M – 1498
2019
Q4
$2.14M Buy
89,026
+15,400
+21% +$351K 0.01% 847
2019
Q3
$1.55M Sell
73,626
-71,100
-49% -$1.47M 0.01% 1004
2019
Q2
$3.19M Buy
144,726
+102,687
+244% +$2.38M 0.02% 727
2019
Q1
$993K Sell
42,039
-18,200
-30% -$425K 0.01% 1005
2018
Q4
$1.34M Sell
60,239
-59,590
-50% -$1.43M 0.01% 827
2018
Q3
$3.12M Sell
119,829
-10,900
-8% -$302K 0.02% 579
2018
Q2
$3.52M Sell
130,729
-8,800
-6% -$233K 0.02% 596
2018
Q1
$3.61M Buy
+139,529
New +$3.81M 0.02% 600

Other funds holding TBI

Mackay Shields LLC's TBI Position: Q2 2021 in Review

Mackay Shields LLC sold out of Trueblue (TBI) in Q2 2021, closing a stake of 83,000 shares — an estimated $1.83M sold.

Mackay Shields LLC first reported a position in TBI in Q1 2018 and held it in 11 quarters. The position peaked at $3.61M in Q1 2018. 172 funds tracked by Wall St. Rank hold TBI as of Q2 2021.

  • Mackay Shields LLC reported no remaining Trueblue position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 83,000 Trueblue shares in Q2 2021, an estimated $1.83M.
  • Mackay Shields LLC first reported a position in Trueblue in Q1 2018 and held it in 11 quarters.
  • Mackay Shields LLC's Trueblue position peaked at $3.61M in Q1 2018.
  • 172 funds tracked by Wall St. Rank held Trueblue as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.